Latest Legal Settlements Suggest Hazards of Making Pharmaceutical Regulation More Lenient, as is Apparently Favored by New FDA Leader

The new US Food and Drug Administration (FDA) commissioner Dr Scott Gottlieb is promoting making the agency's mechanisms to approve new drugs more lenient, according to the Cardiobrief blog.  Blogger Larry Husten wrote:


Gottlieb’s entire career has centered on loosening regulatory restrictions to enable industry to thrive. At the core of his philosophy is the view that with fewer restrictions

Popular posts from this blog

The Virus This Time: Ill-Informed, Incompetent Leadership Enabling Suppression of Free Speech, Intimidation of Whistleblowers, Propaganda and Disinformation

Unfortunately, the rapid progression of coronavirus is providing a demonstration of the dysfunction, and worse, that can be produced by bad leadership in health care and public health. Ill-Informed Leadership During the Trump regime we began to find striking examples of top government officials expressing ill-informed, if not outright ignorant opinions about medical, health care and public
Read more

Guest Post: Coronavirus and the Finger of G-d

Health Care Renewal presents a guest post from Dr Michael Fine, a writer, community organizer, and family physician. He is the chief health strategist for the City of Central Falls, RI, and Senior Clinical and Population Health Services Officer for Blackstone Valley Community Health Care, Inc., and recipient of the Barbara Starfield Award, the John Cunningham Award, and the Austin T. Levy
Read more

COVID-19: Could We Have Been More Ready?

We now see reports of how the US is short of either masks, gowns, doctors, hospital beds, ventilators, community health workers, tests, treatments, or some combination thereof, to manage the new COVID pandemic and the annual influenza season.  We see Congress hustling to adopt a funding package to catch up with the gaps. I just saw, as an attending physician on a busy urban internal medicine
Read more